{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:46:47Z","timestamp":1794358007804,"version":"4.9.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13587-x","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T10:23:28Z","timestamp":1779272608000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical factors associated with mortality in ebola virus disease: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Brandon","family":"Kayembe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beni","family":"Matangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Placide","family":"Matondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Okolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Mbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieudonn\u00e9","family":"Tawaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amede","family":"Kinuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Bepouka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"13587_CR1","volume-title":"Ebola disease: key facts","author":"World Health Organization","year":"2025","unstructured":"World Health Organization. Ebola disease: key facts. Geneva: World Health Organization; 2025."},{"issue":"9768","key":"13587_CR2","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","volume":"377","author":"H Feldmann","year":"2011","unstructured":"Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet. 2011;377(9768):849\u201362.","journal-title":"Lancet"},{"key":"13587_CR3","volume-title":"Ebola virus disease","author":"Centers for Disease Control and Prevention","year":"2024","unstructured":"Centers for Disease Control and Prevention. Ebola virus disease. Atlanta (GA): CDC; 2024."},{"issue":"1721","key":"13587_CR4","doi-asserted-by":"publisher","first-page":"20160308","DOI":"10.1098\/rstb.2016.0308","volume":"372","author":"T Garske","year":"2017","unstructured":"Garske T, Cori A, Ariyarajah A, et al. Heterogeneities in the case fatality ratio in the West African Ebola outbreak 2013\u20132016. Philos Trans R Soc Lond B Biol Sci. 2017;372(1721):20160308.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"1","key":"13587_CR5","first-page":"e1002745","volume":"16","author":"A Forna","year":"2019","unstructured":"Forna A, Nouvellet P, Dorigatti I, et al. Case fatality ratio estimates for the 2013\u20132016 West African Ebola epidemic. PLoS Med. 2019;16(1):e1002745.","journal-title":"PLoS Med"},{"issue":"16","key":"13587_CR6","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1056\/NEJMoa1411100","volume":"371","author":"WHO Ebola Response Team","year":"2014","unstructured":"WHO Ebola Response Team. Ebola virus disease in West Africa: the first 9 months of the epidemic. N Engl J Med. 2014;371(16):1481\u201395.","journal-title":"N Engl J Med"},{"issue":"7","key":"13587_CR7","first-page":"e1001824","volume":"12","author":"G Fitzpatrick","year":"2015","unstructured":"Fitzpatrick G, Vogt F, Gbabai OB, et al. The contribution of Ebola viral load at admission and other risk factors to mortality. PLoS Med. 2015;12(7):e1001824.","journal-title":"PLoS Med"},{"issue":"10121","key":"13587_CR8","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/S0140-6736(17)31795-6","volume":"391","author":"F Lamontagne","year":"2018","unstructured":"Lamontagne F, Cl\u00e9ment C, Fletcher T, et al. Evidence-based guidelines for supportive care of patients with Ebola virus disease. Lancet. 2018;391(10121):700\u20138.","journal-title":"Lancet"},{"issue":"Suppl 3","key":"13587_CR9","first-page":"S193","volume":"214","author":"J Li","year":"2016","unstructured":"Li J, Duan HJ, Chen HY, et al. Age and Ebola viral load correlate with mortality and survival time. J Infect Dis. 2016;214(Suppl 3):S193\u2013200.","journal-title":"J Infect Dis"},{"issue":"4","key":"13587_CR10","first-page":"585","volume":"61","author":"L Hunt","year":"2015","unstructured":"Hunt L, Gupta-Wright A, Simms V, et al. Clinical presentation, biochemical, and haematological parameters and their association with outcome in Ebola virus disease. Clin Infect Dis. 2015;61(4):585\u201392.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"13587_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1056\/NEJMoa1411249","volume":"372","author":"EI Bah","year":"2015","unstructured":"Bah EI, Lamah MC, Fletcher T, et al. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med. 2015;372(1):40\u20137.","journal-title":"N Engl J Med"},{"key":"13587_CR12","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1186\/s12879-019-4547-5","volume":"19","author":"T Yan","year":"2019","unstructured":"Yan T, Mu J, Qin E, et al. Clinical characteristics and outcomes of Ebola virus disease. BMC Infect Dis. 2019;19:873.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"13587_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa1511812","volume":"374","author":"J Van Griensven","year":"2016","unstructured":"Van Griensven J, Edwards T, Baize S, et al. Evaluation of convalescent plasma for Ebola virus disease. N Engl J Med. 2016;374(1):33\u201342.","journal-title":"N Engl J Med"},{"key":"13587_CR14","first-page":"1","volume":"21","author":"LA Skrip","year":"2017","unstructured":"Skrip LA, Galvani AP. Epidemiology and control of Ebola virus disease. Epidemics. 2017;21:1\u20137.","journal-title":"Epidemics"},{"key":"13587_CR15","first-page":"e000140","volume":"1","author":"ET Richardson","year":"2016","unstructured":"Richardson ET, Barrie MB, Kelly JD, et al. Minimally altered care for Ebola patients. BMJ Glob Health. 2016;1:e000140.","journal-title":"BMJ Glob Health"},{"key":"13587_CR16","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"24","key":"13587_CR17","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","volume":"381","author":"S Mulangu","year":"2019","unstructured":"Mulangu S, Dodd LE, Davey RT Jr, Mbaya T, Proschan O, Mukadi M. A randomized controlled trial of Ebola virus disease therapeutics. N Engl J Med. 2019;381(24):2293\u2013303. https:\/\/doi.org\/10.1056\/NEJMoa1910993.","journal-title":"N Engl J Med"},{"issue":"4","key":"13587_CR18","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s10096-016-2840-3","volume":"36","author":"MS Ch\u00e9rif","year":"2017","unstructured":"Ch\u00e9rif MS, Koonrungsesomboon N, Diallo MP, Le Gall E, Kass\u00e9 D, Ciss\u00e9 SD, et al. The predictor of mortality outcome in adult patients with Ebola virus disease during the 2014\u20132015 outbreak in Guinea. Eur J Clin Microbiol Infect Dis. 2017;36(4):689\u201395. https:\/\/doi.org\/10.1007\/s10096-016-2840-3.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"12","key":"13587_CR19","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/cid\/civ202","volume":"60","author":"M Barry","year":"2015","unstructured":"Barry M, Tour\u00e9 A, Traor\u00e9 FA, Sako FB, Sylla D, Kapmy DO, et al. Clinical predictors of mortality in patients with Ebola virus disease. Clin Infect Dis. 2015;60(12):1821\u20134. https:\/\/doi.org\/10.1093\/cid\/civ202.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"13587_CR20","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/tmi.13369","volume":"25","author":"AR Aluisio","year":"2020","unstructured":"Aluisio AR, Perera SM, Yam D, Garbern S, Peters JL, Abel L, et al. Association between treatment with oral third-generation cephalosporin antibiotics and mortality outcomes in Ebola virus disease: a multinational retrospective cohort study. Trop Med Int Health. 2020;25(4):433\u201341. https:\/\/doi.org\/10.1111\/tmi.13369.","journal-title":"Trop Med Int Health"},{"issue":"4","key":"13587_CR21","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/cid\/civ319","volume":"61","author":"E Qin","year":"2015","unstructured":"Qin E, Bi J, Zhao M, Wang Y, Guo T, Yan T, et al. Clinical features of patients with Ebola virus disease in Sierra Leone, 2014. Clin Infect Dis. 2015;61(4):491\u20135. https:\/\/doi.org\/10.1093\/cid\/civ319.","journal-title":"Clin Infect Dis"},{"key":"13587_CR22","doi-asserted-by":"publisher","first-page":"672","DOI":"10.12688\/f1000research.149612.2","volume":"13","author":"TO Yeabah","year":"2025","unstructured":"Yeabah TO, Kaba I, Ramaswamy G, Dahal P, Delamou A, Vonhm BT, et al. Factors associated with death in patients admitted with Ebola virus disease to Ebola treatment units in Guinea, Sierra Leone, and Liberia \u2013 December 2013 to March 2016. F1000Res. 2025;13:672. https:\/\/doi.org\/10.12688\/f1000research.149612.2.","journal-title":"F1000Res"},{"issue":"7","key":"13587_CR23","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.medmal.2019.12.001","volume":"50","author":"MS Sow","year":"2020","unstructured":"Sow MS, Sow DC, Diallo ML, Kass\u00e9 D, Sylla K, Camara A, et al. Ebola virus disease in children in Conakry and Coyah Ebola treatment centers and risk factors associated with death. Med Mal Infect. 2020;50(7):562\u20136. https:\/\/doi.org\/10.1016\/j.medmal.2019.12.001.","journal-title":"Med Mal Infect"},{"key":"13587_CR24","doi-asserted-by":"publisher","unstructured":"Xu Z, Jin B, Teng G, Rong Y, Sun L, Zhang J, et al. Epidemiologic characteristics, clinical manifestations, and risk factors of 139 patients with Ebola virus disease in western Sierra Leone. Am J Infect Control. 2016;44(11):e279\u2013e286. https:\/\/doi.org\/10.1016\/j.ajic.2016.04.216. PMID:27317404.","DOI":"10.1016\/j.ajic.2016.04.216"},{"issue":"7","key":"13587_CR25","doi-asserted-by":"publisher","first-page":"e495","DOI":"10.1016\/S2214-109X(16)30097-3","volume":"4","author":"T Shah","year":"2016","unstructured":"Shah T, Greig J, van der Plas LM, Achar J, Caleo G, Squire JS, et al. Inpatient signs and symptoms and factors associated with death in children aged 5 years and younger admitted to two Ebola management centres in Sierra Leone, 2014: a retrospective cohort study. Lancet Glob Health. 2016;4(7):e495\u2013501. https:\/\/doi.org\/10.1016\/S2214-109X(16)30097-3.","journal-title":"Lancet Glob Health"},{"issue":"4","key":"13587_CR26","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.4269\/ajtmh.17-0090","volume":"98","author":"L Mobula","year":"2018","unstructured":"Mobula L, MacDermott N, Hoggart C, Brantly K, Plyler W, Brown J, et al. Clinical manifestations and modes of death among patients with Ebola virus disease, Monrovia, Liberia, 2014. Am J Trop Med Hyg. 2018;98(4):1186\u201393. https:\/\/doi.org\/10.4269\/ajtmh.17-0090.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"13587_CR27","doi-asserted-by":"publisher","first-page":"pages","DOI":"10.15212\/ZOONOSES-2024-0042","volume":"5","author":"F Isekusu","year":"2025","unstructured":"Isekusu F, Edidi-Atani F, Liesenborghs L, Mavinga A, Tshiani O, Mbala P, et al. Hematologic disorders in Ebola-infected patients during the tenth outbreak in Butembo, Democratic Republic of Congo: hemogram analysis of Ebola virus disease patients during the outbreak in Butembo 2019\u20132020. Zoonoses. 2025;5(1):pages. https:\/\/doi.org\/10.15212\/ZOONOSES-2024-0042.","journal-title":"Zoonoses"},{"key":"13587_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-020-0147-3","volume":"6","author":"ST Jacob","year":"2020","unstructured":"Jacob ST, Crozier I, Fischer WA, et al. Ebola virus disease. Nat Rev Dis Primers. 2020;6:13.","journal-title":"Nat Rev Dis Primers"},{"key":"13587_CR29","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJMoa1604330","volume":"375","author":"PREVAIL II Writing Group","year":"2016","unstructured":"PREVAIL II Writing Group. ZMapp for treatment of Ebola virus disease. N Engl J Med. 2016;375:1448\u201356.","journal-title":"N Engl J Med"},{"issue":"10174","key":"13587_CR30","first-page":"1011","volume":"393","author":"F Lamontagne","year":"2019","unstructured":"Lamontagne F, Fowler RA, Adhikari NKJ, et al. Evolution of supportive care for Ebola virus disease. Lancet. 2019;393(10174):1011\u201321.","journal-title":"Lancet"},{"key":"13587_CR31","first-page":"1838","volume":"382","author":"WHO Ebola Response Team","year":"2020","unstructured":"WHO Ebola Response Team. Ebola virus disease in the Democratic Republic of the Congo, 2018\u20132020. N Engl J Med. 2020;382:1838\u201348.","journal-title":"N Engl J Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13587-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13587-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13587-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:45:16Z","timestamp":1784069116000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13587-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13587"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13587-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1340"}}